pemafibrate
Kowa Pharmaceuticals
['vte']
concern for increased renal adverse events &amp; vte with pemafibrate. and #prominent concluding slides. now published in . #aha22 thread 5/5 
Johns Hopkins Medicine. Associate Professor, Cardiology. Co-Editor in Chief @AJPCardio. #WomenHeartHealth #CardioObstetrics #cvPrev #echofirst She/her #BeKind